These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26259737)

  • 1. [Routine hormonal therapy in the heart transplant donor].
    Zetina-Tun H; Lezama-Urtecho C; Careaga-Reyna G
    Cir Cir; 2016; 84(3):230-4. PubMed ID: 26259737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant.
    Abdelnour T; Rieke S
    J Heart Lung Transplant; 2009 May; 28(5):480-5. PubMed ID: 19416777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term transplant outcomes of donor hearts with left ventricular dysfunction.
    Sibona A; Khush KK; Oyoyo UE; Martens TP; Hasaniya NW; Razzouk AJ; Bailey LL; Rabkin DG
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1865-1875. PubMed ID: 30853225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal resuscitation yields more transplanted hearts, with improved early function.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Apr; 75(8):1336-41. PubMed ID: 12717226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors.
    Dhar R; Marklin GF; Klinkenberg WD; Wang J; Goss CW; Lele AV; Kensinger CD; Lange PA; Lebovitz DJ
    N Engl J Med; 2023 Nov; 389(22):2029-2038. PubMed ID: 38048188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart.
    Casartelli M; Bombardini T; Simion D; Gaspari MG; Procaccio F
    Cardiovasc Ultrasound; 2012 Jun; 10():25. PubMed ID: 22721412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis.
    Novitzky D; Mi Z; Sun Q; Collins JF; Cooper DK
    Transplantation; 2014 Nov; 98(10):1119-27. PubMed ID: 25405914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes After Transplantation of Donor Hearts With Improving Left Ventricular Systolic Dysfunction.
    Madan S; Saeed O; Vlismas P; Katsa I; Patel SR; Shin JJ; Jakobleff WA; Goldstein DJ; Sims DB; Jorde UP
    J Am Coll Cardiol; 2017 Sep; 70(10):1248-1258. PubMed ID: 28859788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial of Intravenous Thyroxine for Brain-Dead Organ Donors With Impaired Cardiac Function.
    Dhar R; Stahlschmidt E; Marklin G
    Prog Transplant; 2020 Mar; 30(1):48-55. PubMed ID: 31802716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors.
    Abuanzeh R; Hashmi F; Dimarakis I; Khasati N; Machaal A; Yonan N; Venkateswaran RV
    Eur J Cardiothorac Surg; 2015 Jan; 47(1):72-7; discussion 77. PubMed ID: 24699201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain death, physiopathology, optimal care and hormonal therapy for cardiac donation].
    Zetina-Tun H; Lezama-Urtecho C; Urías-Báez R; Careaga-Reyna G
    Cir Cir; 2012; 80(6):573-7. PubMed ID: 23336155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.
    Venkateswaran RV; Dronavalli V; Lambert PA; Steeds RP; Wilson IC; Thompson RD; Mascaro JG; Bonser RS
    Transplantation; 2009 Aug; 88(4):582-8. PubMed ID: 19696643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and morphologic adaptation of undersized donor hearts after heart transplantation.
    Mather PJ; Jeevanandam V; Eisen HJ; Piña IL; Margulies KB; McClurken J; Furakawa S; Bove AA
    J Am Coll Cardiol; 1995 Sep; 26(3):737-42. PubMed ID: 7642868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for post-transplant low output syndrome.
    Fujita T; Toda K; Yanase M; Seguchi O; Murata Y; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):551-6. PubMed ID: 22328624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased recovery of thoracic organs after hormonal resuscitation therapy.
    Nath DS; Ilias Basha H; Liu MH; Moazami N; Ewald GA
    J Heart Lung Transplant; 2010 May; 29(5):594-6. PubMed ID: 20207554
    [No Abstract]   [Full Text] [Related]  

  • 16. Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart.
    Bittner HB; Chen EP; Biswas SS; Van Trigt P; Davis RD
    Ann Thorac Surg; 1999 Nov; 68(5):1605-11. PubMed ID: 10585028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiography in the potential heart donor.
    Venkateswaran RV; Townend JN; Wilson IC; Mascaro JG; Bonser RS; Steeds RP
    Transplantation; 2010 Apr; 89(7):894-901. PubMed ID: 20075789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor cardiac troponin-I: a biochemical surrogate of heart function.
    Venkateswaran RV; Ganesh JS; Thekkudan J; Steeds R; Wilson IC; Mascaro J; Thompson R; Bonser RS
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):286-92; discussion 292. PubMed ID: 19394856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing triiodothyronine (T3) with thyroxine (T4) for hemodynamically unstable brain-dead organ donors.
    Dhar R; Stahlschmidt E; Yan Y; Marklin G
    Clin Transplant; 2019 Mar; 33(3):e13486. PubMed ID: 30689222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.